Education hub
Osteosarcoma in dogs: signs and care options
Osteosarcoma is the most common primary bone cancer in dogs — and one of the most aggressive. This guide gathers what veterinary researchers and oncologists currently know, in plain language, so you can walk into every appointment with clearer questions and steadier footing.
Find a veterinary oncologist near youSearch by ZIP code.25,000+
dogs diagnosed each year in the U.S.
75–85%
of canine primary bone tumors are osteosarcoma
~7 yrs
average age at diagnosis
<30%
survival after relapse or metastasis, even with treatment
What osteosarcoma is and which dogs are at risk
Osteosarcoma is a cancer of the bone-building cells. It destroys normal bone from the inside, making the affected limb painful and vulnerable to fracture. About three-quarters of cases occur in the limbs — most often "away from the elbow, toward the knee" — with the rest appearing in the skull, jaw, ribs, spine, or pelvis.
It is primarily a disease of large and giant breeds — Rottweilers, Great Danes, Irish Wolfhounds, Greyhounds, Saint Bernards, German Shepherds, Golden Retrievers, Boxers, Dobermans, Great Pyrenees, Leonbergers, and Scottish Deerhounds are among the most affected — usually appearing around middle to older age. Smaller dogs can get it too, more often in the skull or jaw. Because the disease spreads early and silently, most dogs already have microscopic lung involvement by the time the tumor is found, which is why chest imaging is a standard part of staging.
Early signs of osteosarcoma to watch for
A limp that won't resolve
Unexplained or persistent limping — especially in a large or giant breed — is the most common early sign and deserves a prompt vet visit.
Firm swelling over a bone
A hard, localized swelling that feels attached to the bone itself (not just soft tissue), often near the shoulder, wrist, or knee.
Reluctance to move
Less enthusiasm for walks or play, hesitation on stairs, or guarding one leg. Dogs are experts at hiding pain.
A break without a cause
A fracture from a minor stumble — cancer can weaken bone until it breaks. This always warrants imaging.
None of these signs means cancer by itself. But in an at-risk dog, they deserve a vet's eyes quickly — osteosarcoma moves fast, and early evaluation buys real options.
After the diagnosis
Treatment options after an osteosarcoma diagnosis
Standard of care
Amputation of the affected limb followed by chemotherapy (typically carboplatin) remains the standard playbook. In a large study of 470 dogs, median survival with this approach was about 284 days — roughly nine to ten months — with some dogs living well beyond a year.
Comfort-first paths
For families who decline amputation, palliative radiation, bisphosphonates, and multimodal pain management can control bone pain and protect quality of life. Choosing comfort is a legitimate, loving plan — not a giving-up.
Limb-sparing & emerging options
Limb-salvage surgery is an alternative in selected cases, and newer radiation techniques are being studied to spare healthy tissue. Discuss every path with a board-certified veterinary oncologist.
The frontier
Immunotherapy: teaching the immune system to hunt
Instead of poisoning or cutting out cancer cells, immunotherapy recruits the patient's own immune system to find and destroy them. For canine osteosarcoma, this frontier has moved from clinical trials to licensed medicine in just a few years — and dogs like Rainier were part of how it happened. Read how Rainier took part in an experimental vaccine trial.
ELIAS Cancer Immunotherapy (ECI)
A personalized, autologous cell therapy: the dog's own tumor tissue is used to build a vaccine, and the dog's own T cells are collected, activated, and reinfused to hunt remaining cancer cells. In 2025 it became the first licensed adoptive cell therapy for canine cancer, approved for appendicular osteosarcoma alongside amputation.
The HER2 Listeria vaccine
A University of Pennsylvania–led vaccine trial for dogs with HER2-positive osteosarcoma showed immune responses in most participants and longer survival than historical controls. A larger follow-up trial through the NCI's comparative oncology network (COTC026) published results in 2025.
More trials, more momentum
The NCI's Comparative Oncology Trials Consortium runs studies across 20 academic centers — from inhaled IL-15 to amputation-only palliative arms. Trials are how dogs like Rainier turned their fight into knowledge.
Why dogs matter for people
One cancer, two species
Canine and pediatric osteosarcoma are remarkably similar diseases. Fewer than 1,000 children are diagnosed each year in the U.S. — too rare for fast research progress — while more than 25,000 dogs face the same disease annually, in bodies large enough for real treatment trials, in the same homes breathing the same air.
The National Cancer Institute's Comparative Oncology Program treats pet dogs with cancer in clinical trials designed to advance treatment for both species. Genomic studies have shown canine and human osteosarcoma share key biological features, and findings from dog trials — like the vaccine work above — flow directly into pediatric research. When a dog enrolls in a trial, the trial is also for the children who come after.
Talking with your care team
Questions to ask your veterinary oncologist
- What exactly did the imaging and biopsy show, and has my dog's cancer been staged (including chest imaging)?
- What are all our paths — standard, limb-sparing, palliative, and immunotherapy — and what does each mean for the time and quality of life we might have?
- Is my dog eligible for a comparative oncology clinical trial, and which centers near us participate?
- What is the plan for pain — not just for treatment?
- What should the next two weeks look like, and who do I call when something changes?
Write these down in the printable appointment checklist near the top of this page, or find a board-certified veterinary oncologist by ZIP code.
Please note: this guide is for education and community, not veterinary advice. Decisions about your dog's care belong with your veterinarian or a board-certified veterinary oncologist who knows your dog.
Learn more at the source